+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Transmucosal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2020

  • ID: 5189457
  • Report
  • October 2020
  • Region: Global
  • 221 Pages
  • GlobalData
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

FEATURED COMPANIES

  • AFYX Therapeutics A/S
  • BioXcel Therapeutics Inc
  • Ghent University
  • Lyra Therapeutics
  • Nanosys Inc
  • Rhinomed Limited
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Summary

The publisher's Medical Devices sector report, “Transmucosal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2020“. Transmucosal Drug Delivery device is intended for the localized delivery of medications through a mucous membrane. Usually, drugs are administered through buccal, rectal, vaginal, and nasal routes.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Transmucosal Drug Delivery Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Transmucosal Drug Delivery Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Transmucosal Drug Delivery Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AFYX Therapeutics A/S
  • BioXcel Therapeutics Inc
  • Ghent University
  • Lyra Therapeutics
  • Nanosys Inc
  • Rhinomed Limited

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Transmucosal Drug Delivery Overview
3 Products under Development
3.1 Transmucosal Drug Delivery - Pipeline Products by Stage of Development
3.2 Transmucosal Drug Delivery - Pipeline Products by Segment
3.3 Transmucosal Drug Delivery - Pipeline Products by Territory
3.4 Transmucosal Drug Delivery - Pipeline Products by Regulatory Path
3.5 Transmucosal Drug Delivery - Pipeline Products by Estimated Approval Date
3.6 Transmucosal Drug Delivery - Ongoing Clinical Trials
4 Transmucosal Drug Delivery - Pipeline Products under Development by Companies
4.1 Transmucosal Drug Delivery Companies - Pipeline Products by Stage of Development
4.2 Transmucosal Drug Delivery - Pipeline Products by Stage of Development
5 Transmucosal Drug Delivery Companies and Product Overview6 Transmucosal Drug Delivery- Recent Developments 1607 Appendix
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact
7.4 Disclaimer
List of Tables
Table 1: Transmucosal Drug Delivery - Pipeline Products by Stage of Development
Table 2: Transmucosal Drug Delivery - Pipeline Products by Segment
Table 3: Transmucosal Drug Delivery - Pipeline Products by Territory
Table 4: Transmucosal Drug Delivery - Pipeline Products by Regulatory Path
Table 5: Transmucosal Drug Delivery - Pipeline Products by Estimated Approval Date
Table 6: Transmucosal Drug Delivery - Ongoing Clinical Trials
Table 7: Transmucosal Drug Delivery Companies - Pipeline Products by Stage of Development
Table 8: Transmucosal Drug Delivery - Pipeline Products by Stage of Development
Table 9: AcelRx Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 10: ZALVISO - Product Status
Table 11: ZALVISO - Product Description
Table 12: AcelRx Pharmaceuticals Inc - Ongoing Clinical Trials Overview
Table 13: ZALVISO - Treatment of Acute Post-operative Pain in Patients Undergoing Laparoscopic Colon Resections
Table 14: ZALVISO - Usability and Satisfaction Evaluation of Sufentanil Sublingual Patient-controlled Analgesia after Elective Surgery with Moderate-to-severe Postoperative Pain
Table 15: AFYX Therapeutics A/S Pipeline Products & Ongoing Clinical Trials Overview
Table 16: Rivelin Combo Patch - Product Status
Table 17: Rivelin Combo Patch - Product Description
Table 18: Albert Einstein College of Medicine Pipeline Products & Ongoing Clinical Trials Overview
Table 19: Drug-Impregnated Intravaginal Ring - Product Status
Table 20: Drug-Impregnated Intravaginal Ring - Product Description
Table 21: Allergan Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 22: Vaginal Ring Contraceptive - Product Status
Table 23: Vaginal Ring Contraceptive - Product Description
Table 24: Amphastar Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 25: Intranasal Naloxone Spray - Product Status
Table 26: Intranasal Naloxone Spray - Product Description
Table 27: Anelleo Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 28: AnelleO PRO - Product Status
Table 29: AnelleO PRO - Product Description
Table 30: ARS Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 31: ARS-1 - Product Status
Table 32: ARS-1 - Product Description
Table 33: Auris Medical AG Pipeline Products & Ongoing Clinical Trials Overview
Table 34: AM-125 Betahistine Nasal Spray - Product Status
Table 35: AM-125 Betahistine Nasal Spray - Product Description
Table 36: AM-201 Betahistine Nasal Spray - Product Status
Table 37: AM-201 Betahistine Nasal Spray - Product Description
Table 38: AM-301 Nasal Spray - Product Status
Table 39: AM-301 Nasal Spray - Product Description
Table 40: Auritec Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 41: Versa Intravaginal Ring - Acromegaly - Product Status
Table 42: Versa Intravaginal Ring - Acromegaly - Product Description
Table 43: Versa Intravaginal Ring - Alzheimer's Disease - Product Status
Table 44: Versa Intravaginal Ring - Alzheimer's Disease - Product Description
List of Figures
Figure 1: Transmucosal Drug Delivery - Pipeline Products by Stage of Development
Figure 2: Transmucosal Drug Delivery - Pipeline Products by Segment
Figure 3: Transmucosal Drug Delivery - Pipeline Products by Territory
Figure 4: Transmucosal Drug Delivery - Pipeline Products by Regulatory Path
Figure 5: Transmucosal Drug Delivery - Pipeline Products by Estimated Approval Date
Figure 6: Transmucosal Drug Delivery - Ongoing Clinical Trials
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • AcelRx Pharmaceuticals Inc
  • AFYX Therapeutics A/S
  • Albert Einstein College of Medicine
  • Allergan Ltd
  • Amphastar Pharmaceuticals Inc
  • Anelleo Inc
  • ARS Pharmaceuticals Inc
  • Auris Medical AG
  • Auritec Pharmaceuticals Inc
  • BeFree!
  • Bespak Europe Ltd
  • Biorings LLC
  • BioXcel Therapeutics Inc
  • Bryn Pharma LLC
  • Callitas Therapeutics Inc
  • Combinent BioMedical Systems Inc
  • Conrad
  • Dare Bioscience Inc
  • Emergent BioSolutions Inc
  • Evestra Inc
  • Evoke Pharma Inc
  • EyeGate Pharmaceuticals Inc
  • Ferring Pharmaceuticals AS
  • Ghent University
  • Glenmark Pharmaceuticals Ltd
  • Grunenthal Ltd
  • Hebrew University of Jerusalem
  • Hikma Pharmaceuticals Plc
  • INSYS Therapeutics Inc
  • IntelGenx Corp
  • ITF Pharma Inc
  • Janssen Sciences Ireland UC
  • Karessa Pharma AB
  • Kytogenics Pharmaceuticals Inc
  • Laboratoire HRA Pharma SAS
  • Laboratorios Andromaco
  • Lyra Therapeutics
  • McNeil AB
  • Medlab Clinical Ltd
  • Merck & Co Inc
  • Merck Serono SA
  • Merck Sharp & Dohme Ltd
  • Mithra Pharmaceuticals SA
  • Mucommune LLC
  • Mystic Pharmaceuticals Inc
  • Nanosys Inc
  • NorInvent AB
  • Novus Therapeutics Inc
  • Oak Crest Institute of Science
  • Opiant Pharmaceuticals Inc
  • OptiNose AS
  • OptiNose Inc
  • Orion Biotechnology Canada Ltd
  • Orphanse Healthcare SAS
  • Palette Life Sciences AB
  • Phoenix Life Sciences International Ltd
  • RDD Pharma Ltd
  • Renown Pharmaceuticals Pvt Ltd
  • Rhinomed Limited
  • Scientus Pharma Inc
  • Seelos Therapeutics, Inc.
  • Shin Nippon Biomedical Laboratories Ltd
  • Starpharma Holdings Ltd
  • Suda Pharmaceuticals Ltd
  • The Hong Kong University of Science and Technology
  • Therakind Ltd
  • University of Pittsburgh
  • University of South Florida
  • University of Texas at Austin
  • University of the Witwatersrand
  • University of Washington
  • Washington University in St Louis
  • Zosano Pharma Corp
Note: Product cover images may vary from those shown